Additional file 4 of USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29510504
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 4 of USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition

Figshare
Ubiquitin and proteasome pathways
article

Additional file 4 of USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition

article en

Abstract

No abstract available for this paper.
Figshare
University of Massachusetts Chan Medical School (US), Samsung Medical Center (KR), CHA Vaccine Institute (South Korea) (KR), Sungkyunkwan University (KR)
Zero hunger
Openalex Percentile: Top 53%
Ubiquitin and proteasome pathways
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Additional file 4 of USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition · Figshare (2025) | TGRS Research Map | TGRS